Healthcare -
Biotechnology - NASDAQ - US
$ 0.6601
-5.47 %
$ 83.3 M
Market Cap
-0.63
P/E
KPTI - LONG-TERM DEBT
Long-term Debt KPTI - Karyopharm Therapeutics Inc.
174 M
LAST VALUE
-1.29%
2 YEAR CAGR
11.09%
5 YEAR CAGR
0.00%
10 YEAR CAGR